SCHEMBL3874556

SCHEMBL3874556

CCCCCCCCCCOc1ccc([I+]c2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.64
NR5A1 Q13285 1/20 0.56
TP53 P04637 1/20 0.54
TSHR P16473 1/20 0.54
PLA2G4B P0C869 1/20 0.53
MLNR O43193 1/20 0.51
NR1I2 O75469 1/20 0.51
ESR1 P03372 1/20 0.51
NR3C1 P04150 1/20 0.51
PGR P06401 1/20 0.51
ADRB2 P07550 1/20 0.51
CHRM2 P08172 1/20 0.51
ADRB1 P08588 1/20 0.51
HTR1A P08908 1/20 0.51
ADRA2A P08913 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
CHRM1 P11229 1/20 0.51
DRD2 P14416 1/20 0.51
ADRA2B P18089 1/20 0.51
ADRA2C P18825 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4839363 1.00 LTA4H (0.64) LTA4HNR5A1TP53TSHRPLA2G4B
SCHEMBL6276133 1.00 LTA4H (0.64) LTA4HNR5A1TP53TSHRPLA2G4B
SCHEMBL838064 1.00 LTA4H (0.64) LTA4HNR5A1TP53TSHRPLA2G4B
SCHEMBL145006 1.00 LTA4H (0.64) LTA4HNR5A1TP53TSHRPLA2G4B
SCHEMBL2224932 1.00 LTA4H (0.64) LTA4HNR5A1TP53TSHRPLA2G4B
SCHEMBL12748728 1.00 LTA4H (0.64) LTA4HNR5A1TP53TSHRPLA2G4B
Hydrochloric Acid SCHEMBL3403773 0.98 LTA4H (0.62) LTA4HNR5A1TP53TSHRPLA2G4B
SCHEMBL3200931 0.95 LTA4H (0.63) LTA4HNR5A1TP53TSHRPLA2G4B
SCHEMBL4619982 0.94 LTA4H (0.57) LTA4HNR5A1TP53TSHRPLA2G4B
SCHEMBL2006889 0.94 LTA4H (0.57) LTA4HNR5A1TP53TSHRPLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0565798-B2 Ultraviolet radiation-curable coatings for optical fibers and optical fibers coated therewith BORDEN CHEM INC (US) 2001-03-07 EP claimed
EP-0565798-B1 Ultraviolet radiation-curable coatings for optical fibers and optical fibers coated therewith BORDEN INC (US) 1998-01-14 EP claimed
EP-0334056-B1 Non-toxic aryl onium salts, UV curable coating compositions and food packaging use GEN ELECTRIC (US) 1994-02-02 EP claimed
US-11760817-B2 Mass polymerizable polycycloolefin compositions containing soluble photoacid generators PROMERUS, LLC (US) 2023-09-19 US disclosed
US-7807230-B2 Curcumin and curcuminoid compounds, and use thereof as photosensitizers of onium salts RENSSELAER POLYTECHNIC INSTITUTE (US) 2010-10-05 US disclosed
US-7544721-B2 Photosensitive adhesive composition PRODUITS DENTAIRES PIERRE ROLLAND (FR) 2009-06-09 US disclosed
US-20080260960-A1 Curcumin and Curcuminoid Compounds, and Use Thereof as Photosensitizers of Onium Salts RENSSELAER POLYTECHNIC INSTITUTE (US) 2008-10-23 US disclosed
US-20050182148-A1 Photosensitive adhesive composition PRODUITS DENTAIRES PIERRE ROLLAND (FR) 2005-08-18 US disclosed
EP-1490014-A2 PHOTOSENSITIVE ADHESIVE COMPOSITION Produits Dentaires PIERRE ROLLAND (FR) 2004-12-29 EP disclosed
WO-2003082218-A2 PHOTOSENSITIVE ADHESIVE COMPOSITION PRODUITS DENTAIRES PIERRE ROLLAND (FR) 2003-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760817-B2 Mass polymerizable polycycloolefin compositions containing soluble photoacid generators PPOX, VCL, PFN1 LTA4H 857/4885NR5A1 4698/4885TP53 3284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.